Optometrists in Marathon, FL Accepting Medicare
5 Optometrists found. Showing 1 - 5
 John P Sheldon Od Pa Optometrist Medicare: Medicare Enrolled Practice Location: 6400 Overseas Hwy, Marathon, FL 33050 Phone: 305-743-2020 Fax: 395-743-3937 |
 Dr. Nicole Glaudine Cremata, O.D., PA Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2357 Overseas Hwy, Marathon, FL 33050 Phone: 305-743-6939 Fax: 305-743-6927 |
 Reed West Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2357 Overseas Hwy, Marathon, FL 33050 Phone: 305-743-6939 Fax: 305-743-6927 |
Andrew T Engle, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 554 70th Street Gulf, Marathon, FL 33050 Phone: 240-784-6144 |
Dr. John Patrick Sheldon, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6400 Overseas Hwy, Marathon, FL 33050 Phone: 205-743-2020 Fax: 305-743-3937 |
News Archive
Phase III trial: Rolapitant lessens chemotherapy-induced nausea and vomiting
Rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy, according to the results of a phase III trial presented for the first time today at the ESMO 2014 Congress in Madrid, Spain.
Janssen presents EDURANT 96-week Phase 3 trial data at International AIDS Society Conference
Janssen Therapeutics, Division of Janssen Products, LP, presented today 96-week findings from two pivotal Phase 3 clinical trials, known as ECHO and THRIVE, comparing the efficacy, safety and virology profile of its non-nucleoside reverse transcriptase inhibitor EDURANT tablets versus efavirenz (EFV) in antiretroviral treatment-naive, HIV-1-infected adults.
Generic Hyzaar and Cozaar litigation: Court of Appeals rules in favor of Teva Pharmaceutical Industries
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Court of Appeals for the District of Columbia Circuit has ruled in Teva's favor by overturning a July 31, 2009, district court decision which held that Teva forfeited 180-day marketing exclusivity for its generic versions of Merck's antihypertensive agents Hyzaar® (hydrochlorothiazide; losartan potassium) and Cozaar® (losartan potassium).
Scientists uncover surprising link between brain development and gene tied to breast cancer
Scientists at the Salk Institute have uncovered details into a surprising-and crucial-link between brain development and a gene whose mutation is tied to breast and ovarian cancer.
SMT Research and Development completes first two clinical cases using Shimon Embolic Filter
SMT Research and Development, Ltd., a privately held company, announced that it has completed its first two clinical cases using the Shimon Embolic Filter [SHEF] (TM). SMT R&D developed a novel technology for brain protection (Neuroprotection) from stroke complication hazards arising from invasive cardiology procedures and heart surgery.
› Verified 6 days ago
Physical Therapists
Chiropractors
Optometrists
Podiatrists
Occupational Therapists